Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

Therapeutic approaches for the treatment of head and neck squamous cell carcinoma–An update on clinical trials

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common non-skin cancer with a tobacco consumption and infection with high-risk human papillomavirus (HPV) being major risk factors. Despite advances in numerous therapy modalities, survival rates for HNSCC have not improved considerably...

Full description

Bibliographic Details
Main Authors: Bharat Goel, Anoop Kumar Tiwari, Rajeev Kumar Pandey, Akhand Pratap Singh, Sujeet Kumar, Abhishek Sinha, Shreyans K. Jain, Arun Khattri
Format: Article
Language:English
Published: Elsevier 2022-07-01
Series:Translational Oncology
Subjects:
HNSCC
Immunotherapy
Clinical trial
PD-1
EGFR
Immune checkpoints
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322000857

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322000857

Similar Items